Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer.
Bogani G, Sabatucci I, Maltese G, Lecce F, Signorelli M, Martinelli F, Chiappa V, Indini A, Leone Roberti Maggiore U, Borghi C, Fucà G, Ditto A, Raspagliesi F, Lorusso D. Bogani G, et al. Among authors: maltese g. Eur J Obstet Gynecol Reprod Biol. 2017 Jan;208:41-45. doi: 10.1016/j.ejogrb.2016.11.017. Epub 2016 Nov 19. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 27888705
Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC-IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional Study.
Raspagliesi F, Bogani G, Matteucci L, Casarin J, Sabatucci I, Tamberi S, Arcangeli V, Maltese G, Lepori S, Comerci G, Stefanetti M, Ditto A, Martinelli F, Chiappa V, Lorusso D. Raspagliesi F, et al. Among authors: maltese g. Int J Gynecol Cancer. 2018 Nov;28(9):1706-1713. doi: 10.1097/IGC.0000000000001286. Int J Gynecol Cancer. 2018. PMID: 30376554
RECIST 1.1 criteria predict recurrence-free survival in advanced ovarian cancer submitted to neoadjuvant chemotherapy.
Bogani G, Matteucci L, Tamberi S, Ditto A, Sabatucci I, Murgia F, Arcangeli V, Maltese G, Comerci G, Stefanetti M, Sonetto C, Calareso G, Marchiano A, Chiappa V, Lorusso D, Raspagliesi F. Bogani G, et al. Among authors: maltese g. Eur J Obstet Gynecol Reprod Biol. 2019 Jun;237:93-99. doi: 10.1016/j.ejogrb.2019.04.007. Epub 2019 Apr 8. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 31029972
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study.
Bogani G, Matteucci L, Tamberi S, Arcangeli V, Ditto A, Maltese G, Signorelli M, Martinelli F, Chiappa V, Leone Roberti Maggiore U, Perotto S, Scaffa C, Comerci G, Stefanetti M, Raspagliesi F, Lorusso D. Bogani G, et al. Among authors: maltese g. Int J Gynecol Cancer. 2017 Nov;27(9):1856-1862. doi: 10.1097/IGC.0000000000001108. Int J Gynecol Cancer. 2017. PMID: 29064913
Implementation of Extensive Cytoreduction Resulted in Improved Survival Outcomes for Patients with Newly Diagnosed Advanced-Stage Ovarian, Tubal, and Peritoneal Cancers.
Raspagliesi F, Bogani G, Ditto A, Martinelli F, Chiappa V, Borghi C, Scaffa C, Morano F, Maltese G, Lorusso D. Raspagliesi F, et al. Among authors: maltese g. Ann Surg Oncol. 2017 Oct;24(11):3396-3405. doi: 10.1245/s10434-017-6030-0. Epub 2017 Aug 9. Ann Surg Oncol. 2017. PMID: 28795373
142 results